Teva shares jump as its most promising drug shows exceptional trial results
Teva Pharmaceuticals, in partnership with Sanofi, has announced promising Phase 2 trial results for its drug duvakitug, designed to treat colitis and Crohn’s disease. The drug exceeded expectations, showing significant efficacy compared to the placebo, …